Prophylactic treatment for delayed chemotherapy-induced nausea and vomiting after non-AC based moderately emetogenic chemotherapy: a systematic review of randomized controlled trials-Reference-Cited by-同舟云学术

Prophylactic treatment for delayed chemotherapy-induced nausea and vomiting after non-AC based moderately emetogenic chemotherapy: a systematic review of randomized controlled trials

Published:2015-06-04 Issue:8 Volume:23 Page:2499-2506
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

van der Vorst Maurice J. D. L,Neefjes Elisabeth C. W.,Konings Inge R. H. M.,Verheul Henk M. W.

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-015-2778-6.pdf

Reference32 articles.

1. Bloechl-Daum B, Deuson RR, Mavros P, Hansen M, Herrstedt J (2006) Delayed nausea and vomiting continue to reduce patients’ quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment. J Clin Oncol 24(27):4472–4478

2. Cohen L, de Moor CA, Eisenberg P, Ming EE, Hu H (2007) Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings. Support Care Cancer 15(5):497–503

3. Tonato M, Roila F, Del FA, Ballatori E (1996) Methodology of trials with antiemetics. Support Care Cancer 4(4):281–286

4. Roila F, Ruggeri B, Ballatori E, Del FA, Tonato M (2014) Aprepitant versus dexamethasone for preventing chemotherapy-induced delayed emesis in patients with breast cancer: a randomized double-blind study. J Clin Oncol 32(2):101–106

5. Wymenga AN, van der Graaf WT, Wils JA et al (1996) A randomized, double-blind, multicentre study comparing daily 2 and 5 mg of tropisetron for the control of nausea and vomiting induced by low-dose cisplatin- or non-cisplatin-containing chemotherapy. Ann Oncol 7(5):505–510

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of palonosetron versus granisetron in preventing chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis;European Journal of Clinical Pharmacology;2021-05-15

2. Olanzapine for the prevention and treatment of cancer-related nausea and vomiting in adults;Cochrane Database of Systematic Reviews;2018-09-21

3. Olanzapine Reduces Chemotherapy-induced Nausea and Vomiting Compared With Aprepitant in Myeloma Patients Receiving High-dose Melphalan Before Stem Cell Transplantation: A Retrospective Study;Clinical Lymphoma Myeloma and Leukemia;2017-09

4. Aprepitant in pediatric patients using moderate and highly emetogenic protocols: a systematic review and meta‐analyses of randomized controlled trials;British Journal of Clinical Pharmacology;2017-01-12

5. Efficacy analysis of the aprepitant-combined antiemetic prophylaxis for non-round cell soft-tissue sarcoma patients received adriamycin and ifosfamide therapy;Medicine;2016-12